News Nutriband Supports Update to CDC Opioid Prescribing Guidelines Read More » June 3, 2022 News Nutriband Inc. to Present at the Emerging Growth Conference on May 25 Read More » May 20, 2022 News Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May Read More » May 17, 2022 News Nutriband Subsidiary Active Intelligence LLC Registers with FDA as a Medical Device Manufacturer for its AI Kinesiology Tape Product Read More » May 11, 2022 News Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M Read More » April 29, 2022 News Nutriband Inc.’s patent, ‘Abuse and Misuse deterrent transdermal system’ published by the United States Patent and Trademark Office following recent issuance notice Read More » February 16, 2022 News Nutriband issued full US patent for its AVERSA™ abuse deterrent transdermal platform by United States Patent and Trademark Office. Read More » January 28, 2022 News Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology Read More » January 18, 2022 News Nutriband Inc. and Kindeva Drug Delivery sign feasibility agreement to develop AVERSA™ Fentanyl, an abuse deterrent fentanyl patch Read More » January 10, 2022 « Previous Page1 Page2 Page3 Page4 Page5 Next »
News Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May Read More » May 17, 2022
News Nutriband Subsidiary Active Intelligence LLC Registers with FDA as a Medical Device Manufacturer for its AI Kinesiology Tape Product Read More » May 11, 2022
News Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M Read More » April 29, 2022
News Nutriband Inc.’s patent, ‘Abuse and Misuse deterrent transdermal system’ published by the United States Patent and Trademark Office following recent issuance notice Read More » February 16, 2022
News Nutriband issued full US patent for its AVERSA™ abuse deterrent transdermal platform by United States Patent and Trademark Office. Read More » January 28, 2022
News Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology Read More » January 18, 2022
News Nutriband Inc. and Kindeva Drug Delivery sign feasibility agreement to develop AVERSA™ Fentanyl, an abuse deterrent fentanyl patch Read More » January 10, 2022
